1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Heartflow, Inc. Common Stock

Heartflow, Inc. Common Stock

HTFL
Heartflow, Inc. Common StockUS flagNASDAQ Global Select
24.56
USD
-0.32
- -
2.12BMarket Cap
Heartflow, Inc. Common Stock
HTFL
(NASDAQ Global Select)

Recent

price

24.56

P/E

ratio

- -

div

yld

- -

ROIC.AI

2023
2024
2025
TTM
FRC
1.37
1.56
4.78
2.55
Revenue per Share
-1.94
-1.2
-3.17
-1.49
Basic EPS, GAAP
-1.29
-0.91
-1.6
-1.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
-13.69
-12.04
-29.51
-14.86
Book Value per Share
-11.54
-10.11
8.16
3.81
Tangible Book Value per Share
64
81
37
75
Basic Weighted Avg Shares
87
126
176
191
Sales/Revenue/Turnover
-83.64
-48.66
-36.39
-35.83
Operating Margin (%)
8
8
9
9
Depreciation Expense
-96
-96
-117
-112
Net Income, GAAP
- -
- -
- -
- -
Effective Tax Rate (%)
-109.73
-76.65
-66.35
-58.42
Profit Margin (%)
116
49
178
174
Working Capital
155
155
16
20
LT Debt
-778
-859
301
286
Total Equity
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
6
6
6
LT Borrowings
- -
- -
- -
LT Finance Leases
16
16
20
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
83
85
86
Market Capitalization
2,360
2,151
1,826

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
328
220
212
Cash, Cash Equivalents & STI
291
177
158
Accounts Receivable, Net
28
29
36
Inventories
- -
- -
- -
Total Current Liabilities
38
42
38
Payables & Accruals
29
34
28
ST Debt
6
6
6
Deferred Revenue
1
1
2

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-134.98%
Free Cash Flow
- -
- -
-19.51%
Net Income, GAAP
- -
- -
21.12%
Sales/Revenue/Turnover
- -
- -
39.92%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
27
31
33
35
126
2025
37
43
46
49
176
2026
53
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.33
-0.37
-0.3
- -
-1.2
2025
-0.4
-0.11
-1.04
-0.29
-3.17
2026
-0.32
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
SCWorx Corp. (WORX)
TrivarX Limited (MDBIF)
MSP Recovery, Inc. (LIFWW)
Beijing Health (Holdings) Limited (2389.HK)
AI/ML Innovations Inc. (AIML.CN)
Reliq Health Technologies Inc. (RQHTF)
Business
HeartFlow, Inc. is a medical technology firm that delivers advanced non-invasive solutions globally for the assessment and management of coronary artery disease. Through its HeartFlow Platform, the company leverages artificial intelligence and computational fluid dynamics to construct a unique three-dimensional cardiac model from a routine coronary computed tomography angiography, a specialized imaging technique that yields detailed visuals of the heart's vessels. This advanced platform offers critical insights into coronary blood flow, the degree of arterial narrowing (stenosis), and the characteristics of plaque, thereby enhancing diagnostic capabilities beyond conventional non-invasive assessments. These capabilities help clinicians identify the significance of blockages and avoid unnecessary invasive procedures. Established in 2007, the company maintains its headquarters in Mountain View, California.

Company News

APIChatGPT

  • fool.com

    What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?

  • seekingalpha.com

    HeartFlow: A Premium AI Diagnostics Story

  • globenewswire.com

    New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management

  • fool.com

    Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?

  • fool.com

    Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?

  • fool.com

    HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?

  • seekingalpha.com

    Baron Discovery Fund Q1 2026: Who Moved The Needle

  • fool.com

    Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million?

  • marketbeat.com

    Heartflow Q1 Earnings Call Highlights

  • seekingalpha.com

    HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript

  • globenewswire.com

    Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

  • fool.com

    Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You Money

  • fool.com

    Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors.

  • globenewswire.com

    Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

  • defenseworld.net

    Heartflow, Inc. (NASDAQ:HTFL) Given Average Rating of “Moderate Buy” by Analysts

  • globenewswire.com

    Heartflow Files Patent Infringement Lawsuit Against Cleerly

  • defenseworld.net

    Campbell Rogers Sells 64,533 Shares of Heartflow (NASDAQ:HTFL) Stock

  • prnewswire.com

    How Decentralized AI is Unlocking Value in Cardiac Diagnostics

  • fool.com

    What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale

  • fool.com

    Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?